107 related articles for article (PubMed ID: 6000911)
1. [On peculiarities of the clinical picture and course of circular schizophrenia and the effect of active therapy on it].
Barshteĭn EI; Eryshev OF
Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(2):256-9. PubMed ID: 6000911
[No Abstract] [Full Text] [Related]
2. [A therapeutic pathomorphosis of schizophrenia proceeding with paranoid disorders].
Ozola MIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):600-5. PubMed ID: 5497116
[No Abstract] [Full Text] [Related]
3. [The Wartegg-Sign-Test in schizophrenics].
Knorr W; Rennert H
Fortschr Neurol Psychiatr Grenzgeb; 1966 May; 34(5):276-96. PubMed ID: 5339269
[No Abstract] [Full Text] [Related]
4. Influence of treatment with an amino oxidase inhibitor on the excretion of bufotenin and the clinical symptoms in chronic schizophrenic patients.
Heller B
Int J Neuropsychiatry; 1966 Apr; 2(2):193-203. PubMed ID: 5959966
[No Abstract] [Full Text] [Related]
5. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Wilson LG; Roberts RW; Gerber CJ; Johnson MH
J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
[TBL] [Abstract][Full Text] [Related]
6. [Clinical psychometric evaluation of the effects of fluanxol, oxipertine and chlorpromazine in chronic schizophrenia. Comparative study].
Predescu V; Ciurezu T; Romila A; Pirée S; Vianu I; Ionescu G; Braslă N; Florescu D; David E; Roman I; Zelingher R; Ivana D; Bucurică C; Damian N
Neurol Psihiatr Neurochir; 1969; 14(5):389-400. PubMed ID: 5380156
[No Abstract] [Full Text] [Related]
7. Chlorpromazine in chronic schizophrenia. The effect of age and hospitalization on behavioral dose-response relationships.
Clark ML; Ramsey HR; Rahhal DK; Serafetinides EA; Wood FD; Costiloe JP
Arch Gen Psychiatry; 1972 Oct; 27(4):479-83. PubMed ID: 5072717
[No Abstract] [Full Text] [Related]
8. Clomacran and chlorpromazine in psychotic outpatients: a controlled study.
Case WG; Ryder BL; Dhopeshwarkar VP; Pereira-Ogan JA; Rickels K
Curr Ther Res Clin Exp; 1971 Jun; 13(6):337-43. PubMed ID: 4996219
[No Abstract] [Full Text] [Related]
9. [Effect of prior psychopharmacotherapy on the development, clinical course and therapeutic effect of insulin coma in patients with schizophrenia].
Avrutskiĭ GIa; Neduva AA; Sulukhiia SV; Iakovlev AV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):131-5. PubMed ID: 2658438
[TBL] [Abstract][Full Text] [Related]
10. [Follow-up studies of schizophrenia].
Uno M
Seishin Shinkeigaku Zasshi; 1971 Mar; 73(3):183-220. PubMed ID: 5103106
[No Abstract] [Full Text] [Related]
11. Neuroleptic therapy for chronic schizophrenia.
Ayd FJ
Dis Nerv Syst; 1972 Jan; 33(1):35-9. PubMed ID: 5059687
[No Abstract] [Full Text] [Related]
12. [Insulin-shock treatment in the modern biological therapy of schizophrenia].
Lichko AE
Vestn Akad Med Nauk SSSR; 1971; 26(5):90-2. PubMed ID: 5173010
[No Abstract] [Full Text] [Related]
13. [Febrile states in schizophrenia following a paroxysmal course].
Ermolina LA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(5):731-6. PubMed ID: 5122136
[No Abstract] [Full Text] [Related]
14. [Predicting the effect of psychopharmacotherapy in schizophrenic patients].
Dikiĭ NT
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):110-5. PubMed ID: 6121436
[TBL] [Abstract][Full Text] [Related]
15. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
[No Abstract] [Full Text] [Related]
16. [The course of catatonic schizophrenia].
Kolakowska T
Psychiatr Pol; 1969; 3(3):289-96. PubMed ID: 5805107
[No Abstract] [Full Text] [Related]
17. [On peculiarities of the course of circular schizophrenia and the clinical structure of manic attacks].
Tiganov AS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(8):1250-7. PubMed ID: 5993049
[No Abstract] [Full Text] [Related]
18. Long-term course and prognosis in schizophrenia.
Stephens JH
Semin Psychiatry; 1970 Nov; 2(4):464-85. PubMed ID: 5527412
[No Abstract] [Full Text] [Related]
19. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
[No Abstract] [Full Text] [Related]
20. [Findings on the pathogenesis of serum sickness in schizophrenia].
Il'inskiĭ IuA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):83-7. PubMed ID: 5613009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
